Brief: Irlab Therapeutics Q2 Operating Loss SEK 16.7 Mln
26/08/2026 06:12
BRIEF-Irlab Therapeutics Q2 Operating Loss SEK 16.7 Mln Aug 26 (Reuters) - IRLAB Therapeutics AB IRLABa.ST:
Q2 OPERATING RESULT -SEK 16.7 MILLION
Q2 NET SALES: 6.4 MSEK (19.5 MSEK)
Source text: ID:nMFN60gDTP
Further company coverage: [IRLABa.ST]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))